Pfizer Inc.
COMPOSITIONS AND METHODS FOR COUNTERACTING FACTOR XA INHIBITION
Last updated:
Abstract:
The disclosure provides compositions and methods for counteracting the effects of direct activated Factor X (FXa) inhibitors in a subject by administering a variant of FXa.
Status:
Application
Type:
Utility
Filling date:
16 Mar 2020
Issue date:
7 Jan 2021